Clinical Trials Browser

fluoroazomycin arabinoside × Gastrointestinal × Clear all

NCT03168737 2026-04-15

18F-Fluoroazomycin Arabinoside PET-CT in Diagnosing Solid Tumors in Patients

Phase 1 Active not recruiting

BreastGastrointestinal

Breast Neoplasms, Colonic Neoplasms, Pancreatic Neoplasms